Background Radiofrequency and cryoballoon pulmonary vein isolation are common approaches for paroxysmal atrial fibrillation treatment, showing similar results in recent multicenter studies, including heterogeneous tools and protocols. The aim of this study is to compare prospectively in a single, high-volume center the outcome of paroxysmal atrial fibrillation ablation performed specifically by secondgeneration cryoballoon or contact force radiofrequency ablation.
Introduction
Atrial fibrillation transcatheter ablation is a therapeutic option for rhythm control strategy in patients symptomatic from atrial fibrillation, which is receiving continuously wider recommendations due to its safety and efficacy in the long term compared with antiarrhythmic drug treatment. In particular, atrial fibrillation transcatheter ablation can be proposed for paroxysmal atrial fibrillation when antiarrhythmic drugs fail or are not tolerated, or even as an alternative to antiarrhythmic drug treatment when patients wish not to undergo chronic pharmacological treatment. 1 Conversely to persistent atrial fibrillation, in which the optimal transcatheter ablation approach is still under investigation, as common practice protocols still reach suboptimal results, [2] [3] [4] the mainstay for paroxysmal atrial fibrillation ablation is pulmonary vein isolation. 5 Pulmonary vein isolation can be effectively achieved through different devices (punctual, circular or balloon catheters) and energy sources (radiofrequency, cryoenergy, laser). Recently, a large multicenter randomized trial enrolling patients with paroxysmal atrial fibrillation compared the two most commonly used energy sources, reporting no difference in terms of 1-year outcome alternatively through radiofrequency or cryoballoon ablation. 6 However, in the latter trial, the tools employed and compared were not uniform, as a significant amount of patients were not treated by the last-generation irrigated radiofrequency catheters, with contact force sensing (a feature that helps to confirm stable contact with the tissue during radiofrequency application, resulting in reduced procedural and fluoroscopy times and potentially improved safety), 7, 8 whereas few patients were treated with the first-generation cryoballoon.
The aim of our study is to compare prospectively in a single, high-volume center the safety and efficacy of pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation by second-generation cryoballoon or lastgeneration, contact force, radiofrequency catheters.
Methods
Consecutive patients suffering from paroxysmal atrial fibrillation, as classified by the most recent ESC guidelines, 1 referred to the two Electrophysiology Labs ('Città della Salute e della Scienza' Hospital, Turin, Italy, and 'Cardinal Massaia' Hospital, Asti, Italy) of our Cardiology Department, between January 2015 and December 2016, for a first procedure of transcatheter ablation have been included in this prospective study. All patients signed written informed consent to undergo the procedure. Clinical characteristics of the population, procedural details and follow-up data have been routinely collected and prospectively included in a data registry.
Ablation procedure
Patients were routinely admitted to the hospital 1 day before the ablation. The ablation method, radiofrequency or cryoballoon, was decided casually. According to the principle of planning one cryoablation procedure per week, among patients with paroxysmal atrial fibrillation and no previous catheter ablation attempts, patients referred to cryoablation were selected randomly by the administratives of the hospital; the remaining were referred for radiofrequency ablation. Exclusion criteria were previous ablations, contraindications to anticoagulation, cardiac thrombi.
Oral anticoagulants were continued during the procedure: Warfarin, to maintain an international normalized ratio between 2 and 3 at the time of the procedure; direct oral anticoagulants were withheld only the morning of ablation and restarted in the evening. Before ablation, a transesophageal echocardiogram was performed in all patients to rule out cardiac thrombi. MRI or computerized tomography (CT) scan was performed routinely to assess left atrial dimension, morphology and pulmonary veins pattern.
After femoral vascular access, a decapolar electrode catheter was positioned in the coronary sinus. The left atrial was accessed by transseptal puncture or through a patent foramen ovale, when present. After transseptal puncture, intravenous unfractionated heparin was administered to maintain an activated clotting time of above 350 s.
For radiofrequency ablation, a multipolar catheter (Lasso; Biosense Webster, Irvine, California, USA) and an irrigated-tip ablation catheter with contact force sensing (Thermocool SmartTouch or Thermocool SmartTouch SF; Biosense Webster) were advanced into the left atrial through the same transseptal access. A three-dimensional reconstruction of the left atrial and pulmonary veins ostia, with the use of an electroanatomic mapping system (Carto 3; Biosense Webster) was performed in all patients and merged to preprocedural imaging (cardiac CT or MRI).
The mainstay of the ablation procedure was to obtain complete antral pulmonary veins isolation. Contact force was continuously assessed during ablation, and optimal contact was defined as a contact force range between 5 and 15 g, with stability set as at least 30% of a 6-s time interval over a 3-mm spot. Effective isolation was defined by complete elimination of pulmonary veins potentials, documented by the circular multipolar catheter.
For patients treated by cryoablation, after accessing the left atrial with a single transseptal puncture, the cryoballoon (Arctic Front Advance; Medtronic, Minneapolis, Minnesota, USA) including the circular mapping catheter (Achieve; Medtronic) was advanced in the left atrial. A three-dimensional reconstruction of the left atrial and pulmonary veins ostia, with the use of an electroanatomic mapping system (EnSite Precision; St. Jude Medical, Minneapolis, Minnesota, USA, integrated in our center with MediGuide technology) was performed in all patients through the decapolar mapping catheter (Livewire; St Jude Medical), aiming to identify the pulmonary veins ostia, and merged to preprocedural imaging to reduce radiation exposure. After pulmonary veins cannulation with the Achieve catheter, the cryoballoon was placed at each pulmonary vein ostia, and after confirmation of optimal occlusion through contrast dye injection, cryoenergy was delivered. The protocol included a single, 3-min lesion in case of optimal parameters (minimal temperature lower than À40 8C in 60 s and/or and time to isolation shorter than 45 s), followed by a bonus freeze of 4 min in case of suboptimal parameters, until complete pulmonary vein isolation is obtained. Right-sided pulmonary veins cryoablation was performed during subclavear vein pacing through the decapolar mapping catheter and continuous phrenic nerve capturing to prevent phrenic nerve palsy. Pacing was performed just above capture threshold, 9 and cryoenergy delivery was interrupted in case of phrenic nerve capture loss, waiting for recovery before continuation of the procedure. Effective isolation was defined by complete elimination of pulmonary veins potentials, determined by the circular multipolar catheter.
In case of ineffective isolation of any pulmonary vein following multiple attempts, touch-up with an alternative punctual radiofrequency ablation catheter was considered to achieve pulmonary vein isolation. If concomitant typical atrial flutter was documented, radiofrequency cavo-tricuspid isthmus ablation was performed.
Following the procedure, patients were discharged on oral anticoagulation for at least 1 month, including an antiarrhythmic drug if considered appropriate and tolerated.
Outcomes and follow-up
The main outcomes of the study are acute success in pulmonary vein isolation, defined as pulmonary vein isolation 20 min after the end of ablation with the predefined catheter; safety, measured as the incidence of major complications, defined as life-threatening complications or those requiring interventions or prolonging hospital stay; fluoroscopy time and procedural durations; 1-year freedom from arrhythmic recurrences.
Recurrences were detected by routine ambulatory visits (performed at 3 and 12 months and then yearly), with collection of patients' characteristics, symptoms, ECG and 24/48-h Holter ECG recordings. Arrhythmic recurrences were defined as the presence of documented sustained atrial fibrillation, atypical atrial flutter or atrial tachycardia lasting more than 30 s, respecting a blanking period of 3 months following ablation (defined as 'early recurrences').
Information concerning pharmacological treatment during follow-up, pattern and duration of eventual arrhythmic recurrences were collected in the same registry during follow-up visits.
Statistical analysis
To reduce the effect of selection bias in the assignment of patients to either group propensity score matching was run on the following baseline characteristics: age, sex, weight, atrial fibrillation duration, hypertension, ischemic heart disease, hypertrophic cardiomyopathy, valvular cardiomyopathy, left atrial volume and left ventricular ejection fraction. Of note, other potential predictors of outcome after atrial fibrillation ablation, as atypical pulmonary vein pattern, congenital heart disease and obstructive sleep apnea were not included as rare or not specifically stratified in the present population. None of the other baseline variables not included in the propensity score (e.g. pharmacological baseline therapy) did anyway report statistically significant values in the two groups. After propensity score estimation, the two groups were matched 1 : 1 without replacement (nearest neighbor algorithm), with a caliper equal to 0.15 of the SD of the logit of the propensity score.
Out of consecutive patients undergoing a first atrial fibrillation transcatheter ablation between January 2015 and December 2016, 46 patients approached by cryoablation were matched 1 : 1 by propensity score to a similar population treated by radiofrequency ablation. In this model, the P value of the Hosmer-Lemeshow of goodness of fit was 0.168.
Continuous variables are reported as mean (SD) or median (range), and categorical variables as number (%). Continuous data were compared by one-way analysis of variance test, after normal distribution was confirmed. Categorical variables were compared in cross-tabulation tables by Pearson's Chi-square test or Fisher's Exact Test. Kaplan-Meier curves were used to estimate atrial fibrillation recurrence-free survival over time, stratified by the energy source used.
All tests of significance were two-tailed, and a P value less than 0.05 was considered statisticaly significant. All analyses were performed using SPSS 21.0 (IBM, Armonk, New York, USA).
Results
Baseline characteristics of the two populations after propensity score matching, including overall 92 patients, are described in Table 1 . None of the baseline characteristics was different among the two groups. Considering acute efficacy in pulmonary vein isolation, all patients in the radiofrequency group experienced effective isolation, whereas in the cryoablation group, three patients (overall four pulmonary veins) did not; in these patients, pulmonary vein isolation was finally achieved by radiofrequency touch-up (Table 2) .
After a mean follow-up of 12 AE 5 months, no significant difference in atrial fibrillation recurrences was found between the two groups (24% in radiofrequency vs. 22% in cryoablation group, P ¼ 0.804) (Fig. 1) . Early recurrences presented a nonsignificant trend toward relationship to long-term relapses only among the radiofrequency group (P ¼ 0.220). Radiological exposure was higher for patients in the cryoablation group (11 vs. 4 min in the radiofrequency group, P < 0.001; 34.08 Gy/cm 2 in
Cryoballoon vs. radiofrequency ablation Matta et al. 143 2 (4) 4 (9) 0.398 Diabetes, n (%) 3 (7) 3 (7) 1.000 Heart failure, n (%) 2 (4) 1 (2) 0.557 Previous TIA/stroke, n (%) 1 (2) 0 (0) 0.315 Gastropathy, n (%) the cryoablation vs. 9.42 Gy/cm 2 in the radiofrequency group, P < 0.001), whereas procedural duration did not differ between the two groups (133 min in radiofrequency vs. 124 min in cryoablation group, P ¼ 0.174). Concerning complications, the overall incidence was comparable between the two approaches (4% in radiofrequency vs. 6% in cryoablation group, P ¼ 0.168) ( Table 2 ). However, the pattern of complications was slightly different: in the cryoablation group, two patients experienced vascular access complications and one experienced transient hemoptysis; in the radiofrequency group, one patient experienced a vascular access complication and one pericardial effusion. No life-threatening complications were reported in both groups.
Pulmonary vein anatomy and outcome
The influence of pulmonary vein anatomy on the outcome of cryoballoon or radiofrequency pulmonary vein isolation has been analyzed. In particular, 11 (12%) patients presented 'atypical' pulmonary vein anatomy (left common trunk and/or right intermediate pulmonary vein): no difference in the acute outcome of pulmonary vein isolation nor in the incidence of follow-up arrhythmic recurrences (P ¼ 0.154) was found among patients with 'atypical' pulmonary vein anatomy treated by cryoballoon compared with those treated by radiofrequency ( Table 3 ). The only difference was a trend toward lower acute efficacy in achieving isolation of the right inferior pulmonary vein by cryoballoon compared with radiofrequency (96 vs. 100%, P ¼ 0.307). Despite similar procedural duration (P ¼ 0.341), fluoroscopy time was longer for patients treated by cryoballoon compared with radiofrequency (P < 0.001), also in this subsetting of patients.
Cryoablation learning curve
Of note, this case sample represents the first experience of our group with cryoballoon ablation. Therefore, aiming to assess the effect of the learning curve on the outcome of cryoballoon ablation, the first third of procedures (n ¼ 15) were compared with the following ones ( Table 4) . No difference was found in terms of freedom from atrial fibrillation recurrences (P ¼ 0.720) and complications (P ¼ 0.327). However, longer fluoroscopy time was reported within the first cryoablation procedures (15 vs. 9 min, P < 0.001), along with a nonsignificant trend toward longer procedural duration (133 vs. 119 min, P ¼ 0.120) and more need for intraprocedural touch-up due to failure of cryoballoon pulmonary vein isolation (12 vs. 3%, P ¼ 0.230), especially related to isolation of the right inferior pulmonary vein.
Discussion

Efficacy and safety outcomes
The present is a single, high-volume department prospective study evaluating the outcome of a propensity score adjusted population of paroxysmal atrial fibrillation patients alternatively treated by radiofrequency or cryoballoon ablation of the latest generation. Second-generation cryoballoon and radiofrequency contact force catheters proved similar 1-year freedom from atrial fibrillation recurrences after ablation. In the present experience, ablation efficacy is overall high compared with previous literature; significantly, this result was achieved exposing patients to a limited dose of fluoroscopy and without affecting safety.
Previous studies have, in fact, compared radiofrequency and cryoballoon atrial fibrillation ablation, as the Fire and Ice multicenter randomized trial, 6 however including a large amount of patients treated by previous-generation catheters. Another German multicenter registry 10 and a recent meta-analysis 11 also assessed this topic; however, by not including specifically last-generation catheters, as second-generation cryoballoon has shown improved outcome compared with the first, 12 and improved outcome has also been documented in published experiences on contact force catheters compared with the previous generations, 8, 13 these studies potentially encompass bias. On
Cryoballoon vs. radiofrequency ablation Matta et al. 145 11/11 (100) 6/6 (100) 5/5 (100) -RIPV isolation, n (%) 11/11 (100) 6/6 (100) 5/5 (100) -All PVs isolation, n (%) 11/11 (100) 6/6 (100) 5/5 (100) -Procedural time (min) (SD) 118 (20) 125 (25) 112 ( the other side a study by Squara et al., 14 including patients treated only with second-generation cryoballoon and contact force radiofrequency catheters, reported results similar to ours in terms of both efficacy and complications; due to the observational design, however, several differences among baseline population characteristics were reported, and their impact on the results is unknown.
Of note, isolated early recurrences, frequently described as a transient irritative consequence of transcatheter ablation, 15 presented a nonsignificant difference among the two groups. It is known that radiofrequency relates to a traumatic effect on the atrial tissue structure, resulting in local inflammation and isolated early recurrences during the first months following the procedure. Cryoablation, conversely, presents a more gentle biological effect, potentially limiting irritative effects. 16 However, in the present experience patients in both groups suffered isolated early recurrences, suggesting the presence of a certain amount of myocardial inflammation, probably related to the physical contact with the tissue requested to achieve pulmonary veins occlusion, also following cryoballoon ablation.
Significantly, atypical pulmonary vein patterns were not related to worse acute or mid-term outcome in radiofrequency nor in cryoballoon groups. This finding confirms, as previously described by other authors 17,18 also with alternative 'one-shot' ablation tools, 19 that experienced operators, guided by preprocedural anatomy definition, can manage all pulmonary vein anatomies indifferently with mostly all commonly used ablation tools. The only mark related to pulmonary vein anatomy is that in three patients the right inferior pulmonary vein could not be isolated by cryoballoon. Although not resulting as statistically significant, and being most probably related to the learning curve in cryoballoon ablation (therefore, potentially reducible by operators' experience), this finding warrants consideration.
Concerning safety, the overall incidence of complications did not differ between the two technologies. None of the patients experienced life-threatening complications; more in detail, in the cryoballoon group, there were mainly vascular access-related complications, likely due to the larger diameter of the cryoballoon catheter. These results confirm the findings of previous larger studies, reporting a similar overall incidence of complications. 6, 8, 13, 20 Of note, none of our patients experienced phrenic nerve palsy. The explanation may rely on the phrenic nerve monitoring method, as we performed just above threshold subclavear vein pacing 9 during right-sided pulmonary vein isolation: this, in our opinion, results in an earlier alert that corresponds to only tangential nerve damage, strongly limiting, if not eliminating, the potential risk of persistent phrenic nerve palsy.
Fluoroscopy and procedural times Radiofrequency ablation procedures were characterized by significantly shorter fluoroscopy times, compared with cryoballoon ablation. This finding has already been reported, 6 whereas other studies found no significant difference between the two technologies. 12, 13 The generally lower exposure related to radiofrequency ablation can likely be explained by the strong synergy of this approach with the electroanatomic mapping systems, enabling, in highly trained centers, 'nearly-zero fluoroscopy' ablation procedures. 21, 22 Conversely, cryoablation usually requires radiograph monitoring for manipulation, or at least, as in our study, for confirming pulmonary vein occlusion by venography. Therefore, despite a significant reduction in fluoroscopy time as described with secondgeneration catheters and increased operators' experience, radiograph exposure probably cannot be reduced below a certain level. 23 Overall procedural duration did not differ between the two technologies. Previous studies reported shorter procedural duration for cryoablation, as the balloon-based technology may help to obtain isolation faster than pointby-point technologies. 6, 8, [12] [13] [14] The divergence of our study in this respect most likely relies on two factors. The first is that a three-dimensional reconstruction of the left atrial and pulmonary veins ostia was performed, to minimize radiation exposure, also in the cryoballoon ablation group. This indeed permits navigating the circular mapping catheter outside the distal cryoballoon without continuous fluoroscopy but requires additional mapping time. In our opinion, this investment in time is anyway counterbalanced by the clear reduction of radiation exposure that reflects in reduced risks for both patients and operators. 24, 25 The second is the inclusion of the first operator's experience with cryoballoons, although in a department highly trained in radiofrequency, point-by-point atrial fibrillation ablation. The role of the learning curve in cryoballoon ablation may therefore have impacted the results of this study producing longer procedural time, along with the need in some patients for touch-up radiofrequency applications to reach pulmonary vein isolation. Given this, safety and freedom from atrial fibrillation recurrences among the first cryoablation patients did not differ from the following ones. This finding underlines the relatively steep learning curve with cryoballoon ablation, 26 most probably impacting on top of the need for touch-up to complete pulmonary vein isolation (in particular regarding the right inferior pulmonary vein), only secondary endpoints, as fluoroscopy time and procedural duration. In fact, the large extension of cryoballoon-induced fibrosis at pulmonary vein ostia 27 renders pulmonary vein isolation potentially more reproducible and durable 28 with secondgeneration cryoballoon compared with point-by-point radiofrequency ablation, resulting in a favorable outcome even in case of limited experience.
Limitations
First, the limited study size may bind the strength of the results, in particular referring to statistical relevance of infrequent features such as procedural complications. In addition, the nonrandomized design does not exclude the risk of bias in scheduling patients for each of the alternative procedures; although propensity score matching limits this issue, the optimal study design remains a randomized controlled trial. On the other side, the uniformity related to enrollment in a single department potentially reduces bias introduced by multiple centers' preferences and procedural heterogeneities, leading to a standardized work flow in patients' clinical evaluation, selection, procedural details and follow-up evaluations.
Finally, the extensive use of mapping systems to reduce radiological exposure implies a slight prolongation in procedural duration along with a variable (center-dependent) increase in procedural costs. However, the low incidence of complications, in particular the absence of thromboembolic events or tamponade, underlines the high safety profile of the procedure.
Conclusion
Second-generation cryoballoon and last-generation radiofrequency contact force ablation are equally effective in the mid-term for the treatment of paroxysmal atrial fibrillation; significantly, this result may be achieved by exposing patients to employing a very limited dose use of fluoroscopy and with very high safety profile.
Cryoablation may rarely fail to isolate right inferior pulmonary vein and requires longer fluoroscopy exposure compared with radiofrequency ablation; both of these aspects, however, relate to operators' experience.
